| Vial description: |
MHC class II antigen DRA, HLA-DRA1 |
| Category: |
primary antibody |
| Raised in: |
Mouse |
| Clone: |
1 vial |
| Form: |
FITC |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P01903 |
| Application: |
Immunocytochemistry/Immunofluorescence, F |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
HLA class II DR alpha / HLA-DRA |
| Short name: |
anti-HLA class II DR alpha / HLA-DRA Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
DR a (Antibody to), class II, antibody to-Human leukocyte antigen class II DR a / major histocompatibility aggregate |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BOLA-DRA and IDBG-632808 and ENSBTAG00000010645 and 506214, Cell surfaces, DR alpha, HLA-DRA and IDBG-80796 and ENSG00000204287 and 3122, HLA-DRA1 and MLRW, class II, peptide antigen binding, this GO :0000139 and this GO lgi membrane and cellular component this GO :0002503 and peptide antigen assembly with MHC class II protein complex and biological process this GO :0002504 and antigen processing and presentation of peptide or polysaccharide antigen via MHC class II and biological process this GO :0002506 and polysaccharide assembly with MHC class II protein complex and biological process this GO :0005515 and protein binding and molecular function this GO :0005764 and lysosome and cellular component this GO :0005765 and lysosomal membrane and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0009986 and cell surface and cellular component this GO :0012507 and ER to this GO lgi transport vesicle membrane and cellular component this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0019882 and antigen processing and presentation and biological process this GO :0019886 and antigen processing and presentation of exogenous peptide antigen via MHC class II and biological process this GO :0023026 and MHC class II protein complex binding and molecular function this GO :0030658 and transport vesicle membrane and cellular component this GO :0030666 and endocytic vesicle membrane and cellular component this GO :0030669 and clathrin-coated endocytic vesicle membrane and cellular component this GO :0031295 and T cell costimulation and biological process this GO :0031902 and late endosome membrane and cellular component this GO :0032395 and MHC class II receptor activity and molecular function this GO :0032588 and trans- this GO lgi network membrane and cellular component this GO :0042605 and peptide antigen binding and molecular function this GO :0042613 and MHC class II protein complex and cellular component this GO :0050852 and T cell receptor signaling pathway and biological process this GO :0050890 and cognition and biological process this GO :0060333 and interferon-gamma-mediated signaling pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071556 and integral component of lumenal side of endoplasmic reticulum membrane and cellular component, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0023026 : MHC class II protein complex binding and also this GO :0032395 : MHC class II receptor activity and also this GO :0042605 : peptide antigen binding, this GO :0023026 : MHC class II protein complex binding, this GO :0032395 : MHC class II receptor activity, this GO :0042605 : peptide antigen binding, major histocompatibility complex |
| Identity: |
4947 |
| Gene: |
HLA-DRA |
More about : HLA-DRA |
| Long gene name: |
DR alpha , class II, major histocompatibility complex |
| Synonyms gene: |
HLA-DRA1 |
| Locus: |
6p21, 32 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
3122 |
| RefSeq identity: |
NM_019111 |
| Classification: |
C1-set domain containing Histocompatibility complex |
| Havana BLAST/BLAT: |
OTTHUMG00000031269 |
| Locus Specific Databases: |
IMGT/HLA Database |